Intradermal Vaccination:
The intradermal vaccination segment within the vaccine delivery devices market is projected to witness significant growth in the coming years. This method of administration involves delivering vaccines into the dermis layer of the skin, resulting in enhanced immune response. Factors such as the rising prevalence of infectious diseases and the increasing adoption of intradermal vaccination for diseases like influenza and human papillomavirus are driving the growth of this segment.
Intramuscular Vaccination:
The intramuscular vaccination segment holds a considerable share in the vaccine delivery devices market. This route of administration involves injecting vaccines into the muscle layer, allowing for rapid absorption and immune response. The segment's growth is attributed to the widespread use of intramuscular vaccination for diseases like measles, mumps, and rubella, as well as the growing emphasis on immunization programs globally.
Subcutaneous Vaccination:
The subcutaneous vaccination segment is also expected to gain traction in the vaccine delivery devices market. This method involves administering vaccines into the layer of tissue beneath the skin, leading to a slower but sustained release of the antigen. The segment's growth is fueled by the increasing preference for subcutaneous vaccination for diseases such as hepatitis B and pneumococcal infections, especially among pediatric and geriatric populations.